结核病是造成全世界成年人死亡的主要传染病，在过去 25 年里也一直是全球公共卫生的挑 战。目前唯一批准的结核疫苗只有卡介苗，因此开发安全有效的新型结核疫苗任重而道远。重组亚单位 疫苗成分明确、安全性高、可诱导高效的免疫应答、提供长期的免疫保护效果，因而具有较好的应用前 景。本文针对结核病重组亚单位疫苗的组分、临床研究现状、应用等方面的进展进行综述。

Tuberculosis is still the main infectious disease that causes adult deaths worldwide and has been a global public health challenge for the past 25 years. At present，the only approved tuberculosis vaccine is BCG and there is still a long way to go to develop safer and more effective vaccine of tuberculosis. Recombinant subunit vaccines have clear components，high safety，can induce high⁃efficiency immune responses，and provide long⁃term immune protection effects. So they have good application prospects. This article reviewed the progress in the components，clinical research status，and application of the tuberculosis recombinant subunit vaccine.